Genomic instability in tumors is significantly increased due to endogenous and exogenous factors, such as breast cancer 1/breast cancer 2 (BRCA1/BRCA2) gene mutations and oxidative stress (Chen et al., 2022). The gene discussed is BRCA2; the disease is breast cancer.